EFFECT OF PIRFENIDONE ON EXERCISE CAPACITY AND DYSPNEA IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) AND MORE ADVANCED LUNG FUNCTION IMPAIRMENT

被引：1
|
作者：
Nathan, Steven [1 ]
Bradley, Sarah [1 ]
Costabel, Ulrich [1 ]
Albera, Carlo [1 ]
Behr, Juergen [1 ]
Wuyts, Wim [1 ]
Kirchgaessler, Klaus-Uwe [1 ]
Stauffer, John [1 ]
Morgenthien, Elizabeth [1 ]
Yang, Ming [1 ]
Limb, Susan [1 ]
Noble, Paul [1 ]
机构：
[1] Inova Fairfax Hosp, Annandale, VA USA
来源：
CHEST | 2018年 / 154卷 / 04期
关键词：
D O I：
10.1016/j.chest.2018.08.394
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：432A / 433A
页数：2
相关论文
共 50 条
  • [21] Safety of Combined Pirfenidone and Nintedanib in Subgroups of Patients with Idiopathic Pulmonary Fibrosis (IPF)
    Flaherty, K.
    Fell, C. D.
    Huggins, J. T.
    Nunes, H.
    Sussman, R.
    Valenzuela, C.
    Petzinger, U.
    Stauffer, J. L.
    Gilberg, F.
    Bengus, M.
    Wijsenbeek, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [22] Changes in lung function and mortality risk in patients with idiopathic pulmonary fibrosis (IPF)
    Oldham, Justin M.
    Neely, Megan L.
    Wojdyla, Daniel
    Gulati, Mridu
    Li, Peide
    Patel, Divya
    Palmer, Scott M.
    Todd, Jamie L.
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [23] Efficacy and Safety of Sildenafil Added to Pirfenidone in Patients with Advanced Idiopathic Pulmonary Fibrosis (IPF) and Risk of Pulmonary Hypertension (PH)
    Behr, J.
    Nathan, S. D.
    Wuyts, W. A.
    Bishop, N.
    Bouros, D. E.
    Antoniou, K.
    Guiot, J.
    Kramer, M. R.
    Kirchgaessler, K.
    Bengus, M.
    Gilberg, F.
    Perjesi, A.
    Harari, S.
    Wells, A. U.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [24] Long term efficacy of pirfenidone therapy in patients with idiopathic pulmonary fibrosis (IPF)
    Takaiwa, Takuya
    Tachibana, Hiromasa
    Arita, Machiko
    Ishida, Tadashi
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [25] Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis
    Iwata, Takekazu
    Yoshida, Shigetoshi
    Fujiwara, Taiki
    Wada, Hironobu
    Nakajima, Takahiro
    Suzuki, Hidemi
    Yoshino, Ichiro
    ANNALS OF THORACIC SURGERY, 2016, 102 (06): : 1905 - 1910
  • [26] INSTAGE: A Randomized Trial of Nintedanib Plus Sildenafil Versus Nintedanib Alone in Patients with Idiopathic Pulmonary Fibrosis (IPF) and Advanced Lung Function Impairment
    Kolb, M. R.
    Wells, A.
    Behr, J.
    Richeldi, L.
    Schnaidt, S.
    Quaresma, M.
    Stowasser, S.
    Raghu, G.
    Martinez, F. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [27] Progressive Effect of Pirfenidone on Lung Function in Patients with Idiopathic Pulmonary Fibrosis During the First Year of Treatment
    Llapur, C. J.
    Tabaj, G. C.
    Enghelmayer, J. I.
    Bosio, M. F.
    Alchapar, R. A.
    Victorio, C. F.
    Quadrelli, S. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [28] Effect of Nintedanib on Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis (IPF): Results from a Phase IIIb Trial
    Lancaster, L. H.
    Conoscenti, C. S.
    Ilowite, J.
    Trampisch, M.
    Mogulkoc, N.
    Homik, L.
    Kaye, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [29] Pirfenidone in patients with advanced idiopathic pulmonary fibrosis: First experience
    Hoet, Filip
    Yzerbyt, Jonas
    Wuyts, Wim A.
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [30] Analysis of lung function and survival in RECAP: An open-label extension study of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF)
    Costabel, Ulrich
    Albera, Carlo
    Bradford, Williamson
    Hormel, Phil
    King, Talmadge
    Noble, Paul
    Sahn, Steven
    Valeyre, Dominique
    du Bois, Roland
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
12345